Officer sold
Stock since the trade -2.1% · S&P 500 -1.2% · to Oct 1Traded 62 days after resultsStock 30% above its 52-week low and 9% below its high
Loading…
Globe Life
GL · NYSE · Life & Health Insurance
GL · NYSE · Life & Health Insurance
Life & Health Insurance company based in McKinney, Texas.
Last close, Oct 1, 2026
$165.83
Adjusted for splits and dividends
Last 12 months
+17.6%
S&P 500 +14.3% over the same dates
Market value
$12.7B
Last close × shares outstanding
Bets against the stock: 2.06M shares sold short (2.7% of shares outstanding), +0.0% vs the previous count, 6.2 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
16 sales
$30M sold. Insiders sell for many reasons.
New federal contracts, 12 months
None
Nothing found for this company
Revenue, fiscal 2025
$5.99B
+3.7% vs the year before
Net income, fiscal 2025
$1.16B
As reported in the annual filing
Shares outstanding
76.8M
As of Jul 31, 2026
In fiscal 2025 the company spent $881M buying back its own shares and $86.1M on dividends. Cash actually paid, from its cash-flow statement.
Stock since the trade -2.1% · S&P 500 -1.2% · to Oct 1Traded 62 days after resultsStock 30% above its 52-week low and 9% below its high
Globe Life's & Chief Investment Officer sold $1.13M of Globe Life shares. Nobody planned it ahead of time.
Stock since the trade -2.1% · S&P 500 -1.2% · to Oct 1Traded 62 days after resultsStock 30% above its 52-week low and 9% below its high
22K → 19K shares held−15% of their stake
Globe Life's & Chief Investment Officer sold $567K of Globe Life shares. Nobody planned it ahead of time.
Officer plans to sell ~$1.72M of Globe Life
Planned, from payFrom a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
A securities lawsuit naming the company as a defendant was filed on Apr 30, 2024 in the U.S. District Court, E.D. Texas. A filing is an allegation, not a finding.
City of Miami General Employees' & Sanitation Employees' Retirement Trust v. Globe Life Inc., 4:24-cv-00376Federal civil cases with nature of suit 850 (securities) filed in the last 3 years where the company is the first named defendant, from court records on CourtListener (Free Law Project). Coverage of court records is not complete, and shareholder derivative suits are not included.
Short sale volume: 50.8% of the volume reported to FINRA over the last 20 trading days was marked short, below its 1-year average of 54.4%. FINRA daily files, to Oct 2, 2026.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock.
4 certified in FY2026 Q3, vs 3 a year earlier. 4 positions in total, median offered wage $133K a year.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
Vanguard Capital Management
Schedule 13G: passive · filed Apr 30, 2026 · 5.85M shares
Vanguard Portfolio Management
Schedule 13G: passive · filed Apr 29, 2026 · 4.27M shares
Invesco Ltd.
Schedule 13G: passive · filed May 6, 2026 · 4.02M shares
Anyone owning more than 5% must file within days. Structured filings exist since December 2024, so older stakes that were never amended may be missing.
Last 12 months, adjusted daily closes
Adjusted close went from $140.98 on Oct 1, 2025 to $165.83 on Oct 1, 2026 (+17.6%). Disclosed trades in the last 12 months: 0 insider purchases, 81 insider sales, 1 Congress purchase, 0 Congress sales.